Russell Cox

Russell J.
Cox is Executive Chairman at Epirium Bio, Inc. since 2025.
Mr. Cox is Director at Vascular Cures since 2013.
Mr. Cox is Independent Director at Gossamer Bio, Inc. since 2018.
Formerly, Mr. Cox was Chief Executive Officer & Director at Vital Therapies, Inc. from 2018 to 2019.
Formerly, Mr. Cox was Co-Chief Executive Officer & Director at Immunic, Inc. from 2018 to 2019.
Formerly, Mr. Cox was Chairman at Spyre Therapeutics, Inc. from 2019 to 2024.
Formerly, Mr. Cox was Group Product Manager at Genentech, Inc. from 1987 to 1999.
Formerly, Mr. Cox was Vice President-Marketing at Scios, Inc. from 2003 to 2007.
Formerly, Mr. Cox was Vice President-Marketing at Tercica, Inc. from 2007 to 2008.
Formerly, Mr. Cox was Chief Commercial Officer & EVP at Jazz Pharmaceuticals, Inc. in 2013.
Formerly, Mr. Cox was Chief Commercial Officer & Senior Vice President at Ipsen, Inc. from 2009 to 2010.
Formerly, Mr. Cox was Chief Operating Officer & Executive Vice President at Jazz Pharmaceuticals Plc from 2014 to 2018.
Mr. Cox completed undergraduate education at Texas A&M University in 1985.